Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.

Julg, Boris.Tartaglia, Lawrence J.Keele, Brandon F.Wagh, Kshitij.Pegu, Amarendra.Sok, Devin.Abbink, Peter.Schmidt, Stephen D.Wang, Keyun.Chen, Xuejun.Joyce, M. Gordon.Georgiev, Ivelin S.Choe, Misook.Kwong, Peter D.Doria-Rose, Nicole A.Le, Khoa.Louder, Mark K.Bailer, Robert T.Moore, Penelope L.Korber, Bette T. M.Seaman, Michael S.Abdool Karim, Salim Safurdeen.Morris, Lynn.Koup, Richard A.Mascola, John R.Burton, Dennis R.Barouch, Dan H.2018-03-182018-03-1820172017Julg, B., Tartaglia, L.J., Keele, B.F., Wagh, K., Pegu, A., Sok, D., Abbink, P., Schmidt, S.D., Wang, K., Chen, X., Joyce, M.G., Georgiev, I.S., Choe, M., Kwong, P.D., Doria-Rose, N.A., Le, K., Louder, M.K., Bailer, R.T., Moore, P.L., Korber, B., Seaman, M.S., Abool Karim, S.S., Morris, L., Koup, R.A., Mascola, J.R., Burton, D.R. and Barouch, D.H. 2017. Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge. Science Translational Medicine 9(406), eaal1321.http://hdl.handle.net/10413/15099CAPRISA, 2017.Abstract available in pdf.enBroadly neutralizing antibodies.Antibodies.HIV-1.Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.Peer reviewed journal article